Effectiveness of multidisciplinary team – based medication review using STOPP/START criteria with feedback process on prevalence of potentially inappropriate prescribing in elderly patients with polypharmacy in primary care
Article Sidebar
Main Article Content
Abstract
Objective: To study the effectiveness of multidisciplinary team – based medication review using STOPP/START version 2 criteria with feedback process on reducing prevalence of potentially inappropriate prescribing in elderly patients with polypharmacy in primary care of Prapokklao hospital
Design: Quasi-experimental one – group pretest – posttest design
Materials and Methods: Medication review using STOPP/START version 2 criteria was done in elderly patients aged 65 years and older with chronic diseases and polypharmacy at primary care of Prapokklao hospital for potentially inappropriate prescribing from January 1st, 2020 to March 31st, 2020. We summarized the medication review data and gave feedback to a multidisciplinary team in order to find a successful resolution to potentially inappropriate prescribing. We measured the changes in prevalence of potentially inappropriate prescribing satisfying STOPP and START criteria pre- and post - feedback process. Data were analyzed using descriptive statistics for patient characteristics data and prevalence difference for changes in prevalence of potentially inappropriate prescribing.
Results: A total of 521 participants completed the medication review with feedback process. The intervention significantly decreased prevalence of potentially inappropriate prescribing identified by STOPP for 6.33% (P = .041) and START criteria for 7.49% (P = .001) before and after.
Conclusions: Multidisciplinary team – based medication review using STOPP/START version 2 criteria with feedback process is a strategy that can be implemented in primary care to reduce prevalence of potentially inappropriate prescribing in elderly patients with polypharmacy.
Article Details
The content and information in articles published in the PCFM journal are solely the opinions and responsibilities of the authors. The journal's editorial board does not necessarily agree with or share any responsibility for them.
All articles, information, content, images, etc., published in the PCFM journal are the copyright of the PCFM journal. If any individual or organization wishes to reproduce, distribute, or use any part or the entirety of the content, they must obtain written permission from the PCFM journal beforehand.
References
2. Department of Economic and Social Affairs. World Population Ageing 2015 - Highlights. New York: The United Nations; 2015.
3. Watcharakorn Chewasopit. Aging Society: The Changed Marketing Factor. Journal of MCU Nakhondhat 2019;6:38-54.
4. National Statistical Office. The 2010 population and housing census. 2012 [cited 2019 December 31]. Available from: http://popcensus.nso.go.th/report/WholeKingdom_T.pdf
5. Foundation of Thai Gerontology Research and Development Institute (TGRI). Situation of the Thai elderly 2016. Nakhon Pathom: Printery; 2017.
6. Boss GR, Seegmiller JE. Age-related physiological changes and their clinical significance. West J Med [Internet]. 1981;135(6):434-40. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1273316/pdf/westjmed00220-0011.pdf
7. วิชัย เอกพลากร. การสำรวจสุขภาพประชาชนไทยโดยการตรวจร่างกาย ครั้งที่ 5 พ.ศ.2557. นนทบุรี: สถาบันวิจัยระบบสาธารณสุข; 2559.
8. Nechba RB, Kadiri MEM, Bennani-Ziatni M, Zeggwagh AA, Mesfioui A. Difficulty in managing polypharmacy in the elderly: case report and review of the literature. J Clin Gerontol Geriatr.2015;6(1): 30-33.
9. Farrell B, Shamji S, Monahan A, French Merkley V. Reducing polypharmacy in the elderly: cases to help you “rock the boat”. Can Pharm J (Ott). 2013;146(5):243-244. doi:10.1177/1715163513499530
10. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57-65. doi:10.1517/14740338.2013.827660.
11. Page RL, II SAL, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging 2010; 5:75-87.
12. Ruangritchankul S, Krairit O, Putthipokin K, Chansirikarnjana S, Assavapokee T, Sraium S. Polypharmacy among Older Adults in Outpatient Clinic, Internal Medicine Department, Ramathibodi Hospital. Thai Journal of Toxicology 2018;33(1):35-50.
13. Straand J, Fetveit A, Rognstad S, Gjelstad S, Brekke M, Dalen I. A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practiced the- Prescription Peer Academic Detailing (Rx-PAD) study [NCT00281450]. BMC Health Serv Res. 2006;6:72.
14. O’mahony D, O’sullivan D, Byrne S, O’connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 44:213-8.
15. Panel AGSBCUE, Fick DM, Semla TP, Beizer J, Brandt N, Dombrowski R, et al. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015; 63:2227-46.
16. O’Mahony D, Gallagher P, Ryan C, Byrne S, Hamilton H, Barry P, et al. STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med [Internet]. 2010;1(1):45–51. Available from: http://dx.doi.org/10.1016/j.eurger.2010.01.007
17. Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: A systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360–72.
18. Thomas RE, Thomas BC. A Systematic Review of Studies of the STOPP/START 2015 and American Geriatric Society Beers 2015 Criteria in Patients ≥ 65 Years. Vol. 12, Current Aging Science. 2019. 121–154 p.
19. Projovic I, Vukadinovic D, Milovanovic O, Jurisevic M, Pavlovic R, Jacovic S, et al. Risk factors for potentially inappropriate prescribing to older patients in primary care. Eur J Clin Pharmacol. 2016;72(1):93–107.
20. Bruin-Huisman L, Abu-Hanna A, Van Weert HCPM, Beers E. Potentially inappropriate prescribing to older patients in primary care in the Netherlands: A retrospective longitudinal study. Age Ageing. 2017;46(4):614–9.
21. Nuñez-Montenegro A, Montiel-Luque A, Martin-Aurioles E, Garcia-Dillana F, Krag-Jiménez M, González-Correa J. Evaluation of Inappropriate Prescribing in Patients Older than 65 Years in Primary Health Care. J Clin Med. 2019;8(3):305.
22. Khera S, Abbasi M, Dabravolskaj J, Sadowski CA, Yua H, Chevalier B. Appropriateness of Medications in OlderAdults Living With Frailty: Impact of a Pharmacist-Led Structured Medication Review Process in Primary Care. J Prim Care Community Health. 2019;10.
23. Pengprasop A, Danwilai K.Application of STOPP/START criteria for screening inappropriate medication using in elderly patients with chronic diseases. Srinagarind Med J 2018;33(5):465-71.
24. Samseethong T, Chaekhuntod N, Kewtanong W, Supapaan S, Sripa S. Evaluation of polypharmacy appropriateness in elderly patients using the STOPP/START criteria 2014 at Supphasithipasong hospital, Ubon Ratchathani province. Isan Journal of Pharmaceutical Sciences. 2019;15(3):75-83.
